NVIGEN offers customizable nanoparticle services and prepackaged nanoparticle reagents for research and industry needs. Our bioentity-conjugated nanoparticles, with magnetic and optical properties, provide efficient performance for co-immunoprecipitation, molecular and cell separation, targeted delivery and imaging. Our IP holds tremendous potential for high-sensitivity, high-throughput platforms and partnerships alike.
Our proprietary nanoparticle-imaging-delivery (NID™) technology is a hybrid platform comprised of an intrinsically signal-generating component (i.e. fluorescence and MRI) and a versatile conjugation component that can piggyback payloads for high capacity purification, sensitive and multiplexed imaging and detection, and targeted drug delivery. The NID™ platform is suitable for in vitro and in vivo manipulation. In addition, the modularity of our NID™ platform can be readily integrated into fluidic and therapeutic systems.
Our innovative world’s first molecularly engineered nanoparticles, MagVigen™, offers a unique combination of fluorescent and magnetic nanobeads providing high magnetic moment and bright stable fluorescence, ideal for controllable magnetic manipulation with extensive, multiplexed fluorescence imaging.
Advantages of NVIGEN’s nanoparticle reagents include:
- Optimal water dispersion
- Superior biocompatibility
- High affinity conjugations
- Increased stability
- Enhanced sensitivity
- Targeted delivery and specificity
- Payload applications
- Controllable pharmacokinetics
- Optical contrast enhancement and magnetic properties
- Size tunability
- Multiplex and high-throughput capability